What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%



Code Company Date Close Change Indicator Value Signal

Trading Performance

Volume Rate of Change



Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 99 4.9 0.59% 1.07% 3.9% -2.7% 81.1%
SHORT 97 4.4 0.59% 1.08% 2.5% -4.2% -82.2%


Technical Analysis

Opthea (OPT.AX)



Last Signal:


Trading: SELL @ $3.32
Signal Strength: MEDIUM

Opthea (ASX:OPT) currently has negative rate of change of -30%. This means the current volume is less than the price 14 days ago and therefore losing momentum.

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to detect the speed of movement & give an early signal for a potential movement. By understanding the rate at which the price is moving in respect to the stocks historical trades, enables positions to be set in place based on changes in the speed of movement

Volume Rate of Change Volume (VROC) is an oscillator applied to volume rather than price and is calculated in the same manner as the Rate of Change (Price) indicator. VROC highlights increases in volume which normally occur at most significant market tops bottoms and breakouts.

Calculation: Volume Rate of Change (VROC):
1) ( Volume [today] - Volume [n days ago] ) / Volume [n days ago];


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

Volume Rate of Change

Company Close Change(%) Volume Value Signal
ANG Austin Engineering 0.2 5.3 116,011 -3 BEARISH
SPL Starpharma Holdings 1.2 4.8 106,685 -34 BEARISH
FDV Frontier Digital Ventures 1.14 3.6 44,326 -62 BEARISH
TLG Talga Gold 0.45 3.5 218,924 -12 BEARISH
LAU Lindsay Australia 0.36 2.9 49,777 -25 BEARISH
SNL Supply Network 4.17 2.7 500 -38 BEARISH
CGC Consolidated Gaming Corporation 3.1 2.6 1,524,286 -66 BEARISH
MEZ Meridian Energy 5.38 2.3 11,448 -81 BEARISH
GTK Gentrack 2.23 1.4 10,839 -99 BEARISH
CDV Cardinal Resources 0.37 1.4 81,801 -77 BEARISH